LoginGet started
Picture of IOL Chemicals and Pharmaceuticals logo

IOLCP — IOL Chemicals and Pharmaceuticals Income Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral
Balance sheetIncome statementCashflow
Subscribe to view all data

Annual income statement for IOL Chemicals and Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue16,85318,94519,67021,84022,171
Cost of Revenue
Gross Profit6,1848,0988,4285,8746,404
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses13,08113,56314,13919,81820,370
Operating Profit3,7725,3825,5312,0221,801
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes3,3625,3325,7142,2491,887
Provision for Income Taxes
Net Income After Taxes2,3673,6134,4461,6771,391
Net Income Before Extraordinary Items
Net Income2,3673,6134,4461,6771,391
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income2,3673,6134,4461,6771,391
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS42.163.576.230.523.8
Dividends per Share